# Salix alba (White Willow)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/salix-alba
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-02
**Evidence Score:** 2 / 10
**Category:** European
**Also Known As:** White willow bark, European willow, Weeping willow, Salicis cortex, Weidenrinde, Saule blanc, Corteccia di salice bianco, WW bark extract, Willow bark extract

## Overview

White willow bark (Salix alba) contains salicin, a prodrug converted by gut bacteria and hepatic enzymes to salicylic acid, which inhibits cyclooxygenase (COX) enzymes to reduce [prostaglandin](/ingredients/condition/inflammation) synthesis and inflammation. Unlike synthetic aspirin, its polyphenol and flavonoid co-constituents may contribute additive analgesic and [antioxidant](/ingredients/condition/antioxidant) effects beyond salicin alone.

## Health Benefits

• Pain relief for arthritis and joint conditions - supported by meta-analysis of 6 RCTs (n=329), though evidence quality was rated low due to study limitations
• Migraine prevention - 61.7% reduction in attack frequency shown in small prospective study (n=10 completers, PMID: 17163262)
• Chronic lower back pain management - supported by small clinical studies with limited scale
• Skin health improvement - 2% topical extract improved dark circles and [skin elasticity](/ingredients/condition/skin-health) in 8-week trial (n=29, PMID: 37235713)
• [Anti-inflammatory](/ingredients/condition/inflammation) effects - traditional use supported by prostaglandin inhibition mechanism, though large-scale clinical evidence is limited

## Mechanism of Action

Salicin is hydrolyzed by intestinal microflora to saligenin and glucose, then oxidized hepatically to salicylic acid, which non-selectively inhibits COX-1 and COX-2 enzymes, reducing synthesis of pro-inflammatory prostaglandins and thromboxanes. Unlike aspirin (acetylsalicylic acid), salicylic acid does not irreversibly acetylate COX, resulting in weaker but more gastro-tolerable platelet inhibition. Additional polyphenolic constituents including flavonoids (isoquercitrin, naringenin) and tannins may inhibit NF-κB signaling and lipoxygenase (LOX) pathways, broadening its [anti-inflammatory](/ingredients/condition/inflammation) profile.

## Clinical Summary

A meta-analysis of 6 randomized controlled trials (n=329) found white willow bark extract significantly reduced pain in osteoarthritis and lower back pain conditions, though evidence quality was rated low due to methodological limitations including small sample sizes and heterogeneous preparations. A standardized extract providing 240 mg/day salicin demonstrated a 14-point reduction in WOMAC pain scores versus placebo in one notable RCT. A small prospective study (n=10 completers, PMID: 17163262) reported a 61.7% reduction in migraine attack frequency, though the minimal sample size limits generalizability. Overall, white willow bark shows clinically plausible but not yet conclusively proven efficacy, and head-to-head comparisons with NSAIDs remain limited.

## Nutritional Profile

White willow bark is not a significant source of macronutrients or conventional micronutrients when used medicinally (typically as bark extract, tea, or standardized supplement). Primary bioactive compounds drive its pharmacological relevance:

**Primary Bioactive Compounds:**
• Salicin (primary active glycoside): 1–10% in dried bark depending on species variant, harvest season, and plant part; commercial extracts typically standardized to 15–25% salicin
• Salicortin and tremulacin (additional salicylate prodrugs): present at variable concentrations, contributing to total salicylate load
• Saligenin (aglycone metabolite of salicin): formed via gut bacterial hydrolysis and hepatic oxidation; converted to salicylic acid in vivo — the pharmacologically active end-product
• Total salicylates (as salicin equivalents): approximately 60–120 mg per 240 mg standardized extract dose

**Polyphenols and Flavonoids:**
• Flavonoids (naringenin, isoquercitrin, luteolin glycosides): present at approximately 1–3% in bark; contribute [anti-inflammatory](/ingredients/condition/inflammation) synergy
• Tannins (condensed and hydrolysable): approximately 8–20% in dried bark; astringent properties, may reduce GI absorption of other compounds
• Catechins and procyanidins: present at low concentrations (<1%), [antioxidant](/ingredients/condition/antioxidant) contribution
• Phenolic acids (ferulic acid, caffeic acid): minor constituents

**Bioavailability Notes:**
• Salicin bioavailability is gut-[microbiome](/ingredients/condition/gut-health) dependent; colonic bacteria cleave the glycoside bond to release saligenin, which is then absorbed and oxidized hepatically to salicylic acid
• Peak plasma salicylate levels after salicin ingestion are significantly lower and delayed (Tmax ~2–3 hours) compared to equivalent aspirin doses — partially explaining reduced GI side-effect profile
• Tannin content can bind iron and reduce absorption of co-administered minerals; not a relevant nutritional concern at typical supplemental doses
• Vitamin and mineral content is negligible at standard therapeutic doses (100–240 mg extract); trace amounts of potassium, calcium, and magnesium present in whole bark but not clinically significant
• Fiber content present in whole bark preparations but not in standardized extracts

## Dosage & Preparation

Oral: 300mg standardized extract (0.22% salicin) twice daily for migraine prevention; 240mg/day (15% salicin) for arthritis pain. Topical: 2% bark extract cream applied daily for skin benefits. Standardization typically targets 0.2-15% salicin content. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

White willow bark is generally well tolerated at standard doses (240 mg/day salicin equivalent), with the most common adverse effects being mild gastrointestinal upset, nausea, and rare allergic reactions in salicylate-sensitive individuals. It carries significant interaction risk with anticoagulants (warfarin, heparin), antiplatelet drugs (clopidogrel, aspirin), and NSAIDs due to additive bleeding risk from shared COX inhibition pathways. Concurrent use with methotrexate is contraindicated, as salicylates can reduce its renal clearance and elevate plasma concentrations to toxic levels. It is contraindicated in children under 16 due to theoretical Reye's syndrome risk, and safety in pregnancy and lactation has not been established, making avoidance prudent.

## Scientific Research

A 2023 meta-analysis of five studies (six RCTs, n=329) found willow bark provided pain relief for arthritis patients but noted low evidence quality per GRADE assessment. Smaller studies include a prospective trial (PMID: 17163262) showing 61.7% reduction in migraine frequency with Salix alba 300mg twice daily combined with feverfew, and a topical application study (PMID: 37235713) demonstrating skin improvements.

## Historical & Cultural Context

White willow bark has been used for over 2,000 years in European traditional medicine, dating back to Hippocrates (~400 BCE) for pain relief, fever, [inflammation](/ingredients/condition/inflammation), and rheumatism. As a natural source of salicylates, it historically served as the precursor to modern aspirin.

## Synergistic Combinations

Feverfew (Tanacetum parthenium), Turmeric, Boswellia, Ginger, Devil's Claw

## Frequently Asked Questions

### How much white willow bark should I take for back pain?

Clinical trials demonstrating analgesic benefit for chronic low back pain have used standardized extracts delivering 120–240 mg of salicin per day, with the 240 mg/day dose showing stronger outcomes in at least one RCT. Always choose products standardized to a declared salicin percentage (commonly 15%) to ensure consistent dosing. Consult a healthcare provider before use, particularly if taking blood thinners or NSAIDs.

### Is white willow bark the same as aspirin?

White willow bark and aspirin share a common ancestral compound — salicin is the prodrug precursor to salicylic acid, which inspired the synthesis of acetylsalicylic acid (aspirin) in 1897. However, aspirin irreversibly acetylates COX enzymes and provides stronger, faster platelet inhibition, while salicylic acid derived from salicin acts more gently and without irreversible COX blockade. White willow also contains polyphenols and flavonoids absent in pharmaceutical aspirin that may contribute additional anti-inflammatory mechanisms.

### Can white willow bark cause stomach problems like aspirin does?

White willow bark is generally considered gentler on the gastrointestinal tract than aspirin because salicylic acid — rather than acetylsalicylic acid — does not directly damage gastric mucosa via local acid exposure to the same degree. However, systemic COX-1 inhibition still reduces protective prostaglandin E2 production in the stomach lining, meaning GI discomfort, nausea, or ulceration risk remains possible, especially at high doses or with prolonged use. Individuals with peptic ulcer disease or gastritis should avoid use or consult a physician.

### Does white willow bark interact with blood thinners?

Yes, white willow bark has clinically significant interaction potential with anticoagulants such as warfarin and direct oral anticoagulants (DOACs), as salicylates can displace warfarin from plasma protein binding sites and inhibit platelet thromboxane A2 synthesis, collectively increasing bleeding risk. It should not be combined with antiplatelet drugs like clopidogrel or daily aspirin without medical supervision. Patients on any anticoagulation therapy should disclose white willow bark use to their prescriber before starting.

### Is white willow bark safe during pregnancy?

Safety data for white willow bark during pregnancy and lactation is insufficient to recommend use, and most regulatory bodies and herbalists advise avoidance as a precaution. Salicylates as a class are associated with risks including premature closure of the ductus arteriosus when used in the third trimester, and neonatal bleeding complications. Until controlled safety studies are conducted in pregnant populations, white willow bark supplementation should be avoided during pregnancy and breastfeeding.

### What does clinical research show about white willow bark's effectiveness for arthritis?

A meta-analysis of 6 randomized controlled trials involving 329 participants found that white willow bark provided pain relief for arthritis and joint conditions, though the evidence quality was rated as low due to study limitations such as small sample sizes and methodological constraints. Most positive findings come from short-term studies, and larger, well-designed trials are needed to establish stronger clinical confidence in its efficacy for chronic joint pain management.

### Can white willow bark help prevent migraines, and what does the evidence show?

A small prospective study with 10 completers reported a 61.7% reduction in migraine attack frequency with white willow bark supplementation (PMID: 17163262), suggesting potential migraine prevention benefits. However, this evidence is preliminary and comes from a very limited sample size, so larger clinical trials would be necessary to confirm whether white willow bark is effective for migraine prevention in broader populations.

### Who should avoid white willow bark supplementation?

People with aspirin sensitivity, allergies to salicylates, or certain bleeding disorders should avoid white willow bark since it contains salicin, a salicylate compound. Additionally, individuals taking blood thinners, NSAIDs, or other anticoagulant medications should consult a healthcare provider before use, and it is not recommended during pregnancy or while breastfeeding.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*